GHRS: GH Research PLC Stock

by  •  • Comments Off on GHRS: GH Research PLC Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 466.69
Enterprise Value ($M) 376.63
Book Value ($M) 189.37
Book Value / Share 3.64
Price / Book 2.35
NCAV ($M) 144.70
NCAV / Share 2.78
Price / NCAV 3.23

Profitability (mra)
Return on Invested Capital (ROIC) -0.22
Return on Assets (ROA) -0.18
Return on Equity (ROE) -0.18

Liquidity (mrq)
Quick Ratio 15.83
Current Ratio 15.83

Balance Sheet (mrq) ($M)
Current Assets 154.95
Assets 199.61
Liabilities 10.24
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
4 days ago 13G/A Lynx1 Capital Management LP 8.10 40.14
4 days ago 13G/A Ra Capital Management, L.p. 12.90 19.68
02-14 13G Rtw Investments, Lp 6.40
02-14 13G/A Biotechnology Value Fund L P 19.99 12.13
02-14 13G/A Venrock Healthcare Capital Partners II, L.P. 2.50 -62.52
02-09 13G/A Fmr Llc 6.03 -29.60

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 37,818 173,407 21.81
2024-11-14 16,429 73,609 22.32
2024-11-13 9,739 51,777 18.81
2024-11-12 19,668 68,346 28.78

(click for more detail)

Similar Companies
FOLD – Amicus Therapeutics, Inc. FULC – Fulcrum Therapeutics, Inc.
GANX – Gain Therapeutics, Inc. GLYC – GlycoMimetics, Inc.
HCWB – HCW Biologics Inc.


Financial data and stock pages provided by
Fintel.io